The pleural space is a thin cavity between the two layers of the pleura, which is a membrane that lines the chest wall and lungs. It is filled with a small amount of fluid that helps lubricate the space and enable the lungs to move easily within the chest cavity. When this space becomes filled with an abnormal amount of fluid, it is known as pleural effusion. This condition can be caused by a variety of factors, including infection, tumors, heart failure, and autoimmune diseases. In this article, we will explore the various causes of pleural effusion and how they can be diagnosed and treated.
Pleural effusion is an accumulation of fluid in the pleural space, which can cause discomfort and breathing difficulty. This fluid can be either transudate, which is a non-inflammatory fluid, or exudate, which is an inflammatory fluid. The cause of the effusion can be determined by analyzing the fluid. Common causes of pleural effusion include infection, heart failure, malignancy, and autoimmune diseases.
Infection is one of the most common causes of pleural effusion, particularly in children. The most common causes of infection-related pleural effusion are pneumonia, tuberculosis, and other respiratory viruses. In some cases, the infection can spread to the pleural space and cause an accumulation of fluid.
Another common cause of pleural effusion is heart failure. When the heart is unable to pump enough blood around the body, it can cause fluid to back up in the lungs and pleural space. This can lead to an accumulation of fluid in the pleural space, resulting in pleural effusion.
Malignancy, or cancer, can also cause pleural effusion. Cancer cells can spread to the pleural space and cause an accumulation of fluid. This can be seen in lung cancer, mesothelioma, and other types of cancer.
Autoimmune diseases, such as rheumatoid arthritis, lupus, and scleroderma, can also cause pleural effusion. In these cases, the body’s immune system attacks the pleural space, resulting in an accumulation of fluid.
Pleural effusion is typically diagnosed through imaging tests, such as chest X-rays or CT scans. Once the effusion has been confirmed, the cause must be determined. This can be done through a variety of tests, including a pleural fluid analysis, a pleural biopsy, or a thoracentesis. Once the cause of the effusion has been determined, treatment can begin. Treatment will vary depending on the cause of the effusion, but may include antibiotics for infection, diuretics for heart failure, chemotherapy for cancer, or immunosuppressive drugs for autoimmune diseases.
Pleural effusion is an accumulation of fluid in the pleural space. It can be caused by a variety of factors, including infection, heart failure, malignancy, and autoimmune diseases. Diagnosis is typically done through imaging tests, such as chest X-rays or CT scans, and treatment will vary depending on the cause. With proper diagnosis and treatment, pleural effusion can be managed and the patient’s quality of life can be improved.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation